Ibandronate Sodium Injection
Product Images NDC 60505-6097

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ibandronate Sodium (NDC 60505-6097). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Ibandronate 01)

Figure 1 (Ibandronate 01)
This text appears to be discussing two different dosage options for increasing Lumbar Spine BMD (bone mineral density) and their effectiveness. The first option is a daily 2.5mg dose, while the second option is a 3mg dose given once every three months either orally or intravenously. The study mentioned compared the two dosages and found that the 3mg every 3 months was more effective, with a statistically significant difference (p<0.001).*
FDA Label Image

Figures 2 (Ibandronate 02)

FDA Label Image

Ibandronate-04 (Ibandronate 04)

FDA Label Image

Ibandronate-05 (Ibandronate 05)

Ibandronate-05 (Ibandronate 05)
Ibandronate Sodium Injection is a sterile, single-use, prefilled syringe with a quantity of 3 mg*/3 mL (1 mg/mL), to be used intravenously only. It contains Ibandronate sodium monohydrate, equivalent to 3 mg ibandronate free acid. It is accompanied by prescribing information and should be stored at temperatures between 15°C-30°C (59°F-86°F). Unused portions of the solution should be discarded. It is manufactured in India by Gland Pharma Limited and distributed by Apotex Corp. in Weston, Florida.*
FDA Label Image

Chemical Structure (Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.